Subcutaneous immunotherapy is a unique therapy for allergic disease because it provides symptomatic relief while modifying the allergic disease by targeting the underlying immunological mechanism.

Figure 3 Subcutaneous injection of zein up to 5 days before skin injury improved the pattern of collagen arrangement. A - C, Representative sections of intact skin or wounds harvested 40 days after ...

Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that ...

argenx Announces European Commission Approval of VYVGART Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy Published Jun 20, 2025 1:00pm EDT ...